Anthony Jake Demetris – 18 October 2006 – Key Concepts: 1Recurrent primary sclerosing cholangitis (PSC) is extremely difficult, if not impossible, to distinguish from other causes of biliary strictures or sclerosing cholangitis in allografts using needle biopsy evaluation alone.
Lydia M. Petrovic – 18 October 2006 – Key Concepts: 1Early recurrence of hepatitis C is universal.2Typical histopathologic features of hepatitis C virus (HCV) and acute allograft rejection (AAR) exist.3Early recurrent HCV may be differentiated from AAR.4Liver biopsy plays a role in diagnosing HCV and AAR.5Risk factors for recurrent HCV should be known.6The natural history of recurrent HCV should be known.7The future role of ancillary studies beyond liver biopsy is assessed. Liver Transpl 12:S32–S37, 2006. © 2006 AASLD.
Debra L. Sudan – 18 October 2006
Laura E. Moreno Luna, Gregory J. Gores – 18 October 2006
Michael F. Sorrell – 18 October 2006
Nathan M. Bass, Bernard C. Portmann, Michael R. Lucey – 18 October 2006
Swan N. Thung – 18 October 2006 – Key Concepts: 1The histopathologic presentation of hepatitis B (HB) infection in liver allografts is generally similar to that seen in the nonallografts.2An atypical pattern of recurrent HB, i.e., fibrosing cholestatic hepatitis (FCH) occurs in a small number of patients.
Timothy McCashland – 18 October 2006
Alberto Grassi, Chiara Quarneti, Matteo Ravaioli, Francesco Bianchini, Micaela Susca, Antonia D'Errico, Fabio Piscaglia, Maria Rosa Tamè, Pietro Andreone, GianLuca Grazi, Silvia Galli, Daniela Zauli, Antonio D. Pinna, Francesco B. Bianchi, Giorgio Ballardini – 9 October 2006 – The aim of this study was to evaluate how the immunohistochemical detection of liver hepatitis C virus (HCV) antigens (HCV‐Ag) could support the histologic diagnosis and influence the clinical management of post‐liver transplantation (LT) liver disease.